Top Pentagon AI Official Sold Millions in Perplexity Stock, Disclosures Show
Emil Michael's latest financial filings show a summer exit from Perplexity, months after a January sale of xAI stock that reportedly netted him up to $24 million.
Anthropic Gives Retailers Blueprint for AI Shopping Agents
Anthropic is giving retailers a set of blueprints to build artificial intelligence agents that can help shoppers find products and assist merchants with tasks including inventory, pricing and marketing, as retailers prepare for the holiday shopping season.…
The AI company announced the blueprint Wednesday (Sept.
Reuters reported that the initiative comes as shoppers increasingly us…
Adobe Analytics said last month that visits to retail sites driven by …
STAT+: Ultragenyx drug to treat Angelman syndrome, a rare disease, fails late-stage trial
The biotech company Ultragenyx said Wednesday that its experimental therapy for Angelman syndrome, a rare disease that causes severe intellectual disabilities and developmental delays, showed no benefit compared to a sham treatment in a large Phase 3 trial.…
The drug, GTX-102, had shown powerful results in early trials, raising…
Many advocates for patients with other neurological conditions also ho…
The news is a significant blow for Ultragenyx’s business as well.
Amouage Raises Concentration Stakes With Decision 42 and Overture 41
The $550 extraits arrive alongside a Nez study “What Is Concentration” that tracks a 2026 wave of extrait launches from Chanel to Byredo and argues the format has become fine fragrance’s premiumization lever of choice.